Ozemback
Regulatory

Peptide and GLP-1 regulation: FDA rules, the 503A list and what is legal

Most of what people believe about peptide legality comes from someone selling peptides. This desk tracks the rules themselves: what the FDA has approved, what a compounding pharmacy may lawfully prepare, what the July 2026 committee vote did and did not settle, and where each compound stands right now.

A recommendation from an advisory committee is not a rule. Until the FDA acts, the legal position of most peptides is unsettled, and anyone telling you otherwise is guessing or selling.

11 articles in this desk
Ozemback is independent journalism. Nothing on this site is medical advice. Nothing replaces a licensed clinician. Read the disclaimer